Usefulness of the probiotic 'Lactobacillus reuteri' in the therapy of habitual eradication of infection Helicobacter pylori,

Registry ID
EUCTR2017-000342-22
Source registry
EUCTR
Status
Completed
Phase
PHASE4
Sponsor
Dr. Luis Fernández-Dr. Jesus Barrio
Start date
2017-04-04
Completion date
2018-08-01
Last update
2026-08-16

Conditions

Summary

To know if supplementation with Gastrus (food supplement) vs Placebo is able of lowering the gastrointestinal adverse effects of quadruple eradication therapy determined by the GSRS gastrointestinal symptom scale in routine clinical practice.

Locations

View on source registry